Valion Bio VBIO
NASDAQ VBIO
$0.12 +0.00 (+0.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Gross Margin (2021 - 2026)

Valion Bio (VBIO) posted quarterly Gross Margin of 91.25% for Q4 2025, up 22403.0% year-over-year from N/an in Q4 2024, and up 191.88% quarter-over-quarter from 99.32% in Q3 2025.

Valion Bio (VBIO) Gross Margin (2021 - 2026) Analysis & Trends

Valion Bio's Gross Margin history runs 5 years deep, the most recent figure standing at 91.25% for Q4 2025.

  • In Q4 2025, Gross Margin rose 22403.0% year-over-year to 91.25%; the TTM figure through Dec 2025 stood at 8.38% (up 812.0% YoY), while the FY2025 annual figure was 8.38%, up 812.0% from the prior year.
  • Gross Margin for Q4 2025 stood at 91.25%, up from 99.32% in the prior quarter.
  • The five-year high for Gross Margin was 91.25% in Q4 2025, with the low at 132.78% in Q4 2024.
  • The 5-year median for Gross Margin is 18.89% (2024), against an average of 12.79%.
  • Peak annual rise in Gross Margin reached 22403 bps in 2025, while the deepest fall reached 13424 bps in 2025.
  • Valion Bio's Gross Margin stood at 0.51% in 2021, then soared by 2150 bps to 10.54% in 2022, then slumped by 87 bps to 1.4% in 2023, then slumped by 9580 bps to 132.78% in 2024, then jumped by 169 bps to 91.25% in 2025.
  • Business Quant data shows VBIO's Gross Margin at 91.25% in Q4 2025, 99.32% in Q3 2025, and 62.79% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 91.59%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 90.43%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 35.86%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 89.76%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 76.90%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 63.27%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 84.20%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Valion Bio 405,599.63 -1.79 Mn -45,000.00 -115.38%

Historic Data

Download Data
DateValue
Jun 30, 2026 -115.38%
Dec 31, 2025 91.25%
Sep 30, 2025 -99.32%
Jun 30, 2025 62.79%
Mar 31, 2025 71.43%
Dec 31, 2024 -132.78%
Sep 30, 2024 34.92%
Jun 30, 2024 21.43%
Mar 31, 2024 50.00%
Dec 31, 2023 1.40%
Sep 30, 2023 38.30%
Jun 30, 2023 37.89%
Mar 31, 2023 30.05%
Dec 31, 2022 10.54%
Sep 30, 2022 13.21%
Jun 30, 2022 23.67%
Mar 31, 2022 16.36%
Dec 31, 2021 -0.51%
Sep 30, 2021 -9.39%
Jun 30, 2021 -12.31%